arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2602.04063cs.CV

iSight:迈向专家-人工智能协同评估以提高免疫组化染色解释

iSight: Towards expert-AI co-assessment for improved immunohistochemistry staining interpretation

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania(病理与实验室医学系,佩尔曼医学院,宾夕法尼亚大学);Department of Electrical and Systems Engineering, University of Pennsylvania(电气与系统工程系,宾夕法尼亚大学);Department of Biomedical Data Science, Stanford University School of Medicine(生物医学数据科学系,斯坦福大学医学院);Department of Pathology, University of Maryland School of Medicine(病理学系,马里兰大学医学院);Department of Pathology, Stanford University School of Medicine(病理学系,斯坦福大学医学院)
Jacob S. Leiby, Jialu Yao, Pan Lu, George Hu, Anna Davidian, Shunsuke Koga, Olivia Leung, Pravin Patel, Isabella Tondi Resta, Rebecca Rojansky, Derek Sung, Eric… 展开作者

Jacob S. Leiby, Jialu Yao, Pan Lu, George Hu, Anna Davidian, Shunsuke Koga, Olivia Leung, Pravin Patel, Isabella Tondi Resta, Rebecca Rojansky, Derek Sung, Eric Yang, Paul J. Zhang, Emma Lundberg, Dokyoon Kim, Serena Yeung-Levy, James Zou, Thomas Montine, Jeffrey Nirschl, Zhi Huang

AI总结:

iSight通过多任务学习框架提升IHC染色评估的准确性,优于基础模型并改善专家一致性。

摘要:

免疫组化(IHC)为组织切片中的蛋白质表达提供信息,并常用于支持病理诊断和疾病分诊。尽管用于H&E染色切片的AI模型显示出潜力,但其在IHC中的适用性受到领域特定差异的限制。在此,我们介绍了HPA10M数据集,该数据集包含来自人类蛋白图谱的10,495,672张IHC图像,并包含详尽的元数据,涵盖45种正常组织类型和20种主要癌症类型。基于HPA10M,我们训练了iSight,一种多任务学习框架,用于自动化IHC染色评估。iSight通过令牌级注意力机制结合整张滑动图像的视觉特征和组织元数据,同时预测染色强度、位置、数量、组织类型和恶性状态。在保留数据上,iSight在位置、强度和数量上的准确率分别达到85.5%、76.6%和75.7%,优于微调的基础模型(PLIP、CONCH)2.5-10.2%。此外,iSight的预测具有良好的校准,预期校准误差为0.0150-0.0408。此外,在八名病理科医生评估来自两个数据集的200张图像的用户研究中,iSight在保留的HPA数据集上优于初始病理科医生评估(位置79% vs 68%,强度70% vs 57%,数量68% vs 52%)。在保留的HPA(Cohen's κ值从0.63增加到0.70)和斯坦福TMAD数据集(从0.74增加到0.76)中,跨病理科医生的一致性也有所提高,表明专家-人工智能协同评估可以提高IHC解释。这项工作为能够提高IHC诊断准确性的AI系统奠定了基础,并突显了将iSight整合到临床工作流程中以提高IHC评估一致性和可靠性的潜力。

英文摘要:

Immunohistochemistry (IHC) provides information on protein expression in tissue sections and is commonly used to support pathology diagnosis and disease triage. While AI models for H\&E-stained slides show promise, their applicability to IHC is limited due to domain-specific variations. Here we introduce HPA10M, a dataset that contains 10,495,672 IHC images from the Human Protein Atlas with comprehensive metadata included, and encompasses 45 normal tissue types and 20 major cancer types. Based on HPA10M, we trained iSight, a multi-task learning framework for automated IHC staining assessment. iSight combines visual features from whole-slide images with tissue metadata through a token-level attention mechanism, simultaneously predicting staining intensity, location, quantity, tissue type, and malignancy status. On held-out data, iSight achieved 85.5\% accuracy for location, 76.6\% for intensity, and 75.7\% for quantity, outperforming fine-tuned foundation models (PLIP, CONCH) by 2.5--10.2\%. In addition, iSight demonstrates well-calibrated predictions with expected calibration errors of 0.0150-0.0408. Furthermore, in a user study with eight pathologists evaluating 200 images from two datasets, iSight outperformed initial pathologist assessments on the held-out HPA dataset (79\% vs 68\% for location, 70\% vs 57\% for intensity, 68\% vs 52\% for quantity). Inter-pathologist agreement also improved after AI assistance in both held-out HPA (Cohen's $κ$ increased from 0.63 to 0.70) and Stanford TMAD datasets (from 0.74 to 0.76), suggesting expert--AI co-assessment can improve IHC interpretation. This work establishes a foundation for AI systems that can improve IHC diagnostic accuracy and highlights the potential for integrating iSight into clinical workflows to enhance the consistency and reliability of IHC assessment.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑